Related Experiment Video
Updated: Jun 23, 2026

Modifying Levels of Maternal Dietary Folic Acid or Choline to Study the Impact of Deficiencies on Offspring Health Outcomes
Published on: June 28, 2024
Comparative Investigation of Alcohol and Substance Use Disorder Patients in Terms of Folate Deficiency
Muhammed Raşit Bardakçı1, Ahmet Bulent Yazici2
1Clinic of Psychiatry, Sakarya Training and Research Hospital, Sakarya, Turkey.
Background:
Nutritional disorders are common in patients with Alcohol Use Disorder (AUD) or Substance Use Disorder (SUD) and can lead to vitamin deficiencies such as Folate Deficiency (FD). The aim of this study was to investigate folate levels and the presence of FD in AUD or SUD patients by comparing them according to the type of substance used.
Methods:
A total of 633 AUD or SUD patients were included in this retrospective file review study. Patients were divided into four groups based on the substance they used: Alcohol (n = 217), Cannabinoid (n = 71), Methamphetamine (n = 296) and Opiates (n = 49) and analyzed comparatively in terms of sociodemographic data, folate levels and FD status.
Results:
In AUD or SUD patients, mean folate levels (H = 110.249, p < 0.001), FD status differ according to the type of substance used (χ2 = 31.715, p < 0.001). Mean folate levels were significantly lower (p < 0.0083) in the Methamphetamine group compared to the Alcohol and Cannabinoid groups, while Possible Folate Deficiency (PFD) was significantly higher in the methamphetamine group (p < 0.0083). FD was significantly higher in the Alcohol, Methamphetamine and Opiate groups compared to the Cannabinoid (p < 0.0083).
Conclusions:
FD status in AUD or SUD patients varies according to the type of substance used. In these patients, especially those in the methamphetamine group and the alcohol and opiate groups, improving nutrition and folic acid supplementation may contribute to recovery.
More Related Videos
19:57The Use of Trace Eyeblink Classical Conditioning to Assess Hippocampal Dysfunction in a Rat Model of Fetal Alcohol Spectrum Disorders
Published on: August 5, 2017
07:31Murine Drinking Models in the Development of Pharmacotherapies for Alcoholism: Drinking in the Dark and Two-bottle Choice
Published on: January 7, 2019
Related Concept Videos
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Bioavailability Study Design: Healthy Subjects Versus Patients